Literature DB >> 18842620

Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells.

Robert T Taylor1, Feng Wang, Erin L Hsu, Oliver Hankinson.   

Abstract

Cytochrome P450 (CYP) 1A1 and CYP1B1 are inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) in the human breast cancer cell line, MCF-7. Since CYP1A1 was inducible to a much greater degree than CYP1B1, we hypothesized that there may be differences in coactivator recruitment to the promoter and/or enhancer regions of these genes. Dioxin treatment leads to recruitment of the aryl hydrocarbon receptor to the enhancer regions but not to the proximal promoter regions of both the CYP1A1 and CYP1B1 genes. On the other hand, dioxin treatment facilitated recruitment of RNA polymerase II to the promoters but not the enhancer regions. Dioxin treatment also elicited recruitment of the transcriptional coactivators, steroid receptor coactivator 1 (SRC-1) and steroid receptor coactivator 2 (SRC-2) and p300, which possess intrinsic histone acetyltranferase activities, to both genes, whereas Brahma (BRM)/Switch 2-related gene 1 (BRG-1), a subunit of nucleosomal remodeling factors, was recruited more robustly to CYP1A1 relative to CYP1B1. Small inhibitory RNA-mediated knockdown of p300 and SRC-2 adversely affected dioxin induction of both genes, whereas knockdown of BRM/BRG-1 reduced CYP1A1 induction but had little, if any, effect on CYP1B1 induction. These results suggest that nucleosomal remodeling is less significant for dioxin-mediated induction of CYP1B1 than that of CYP1A1 and may be related to the more modest inducibility of the former. Interestingly, simultaneous knockdown of SRC-2 and BRM/BRG-1 had no greater effect on CYP1A1 induction than knockdown of each coactivator individually, while simultaneous knockdown of p300 and BRM/BRG-1 had a much greater effect than knockdown of each individual gene, suggesting that the recruitment of SRC-2 to CYP1A1 depends upon BRM/BRG-1, while the recruitments of p300 and BRM/BRG-1 are independent of each other. These observations provide novel insights into the functional roles of the endogenous coactivators in dioxin induction of the human CYP1A1 and CYP1B1 genes in their natural chromosomal configurations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18842620      PMCID: PMC2638648          DOI: 10.1093/toxsci/kfn217

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  35 in total

1.  Identification of a novel dioxin-inducible cytochrome P450.

Authors:  Steven P Rivera; Sirkku T Saarikoski; Oliver Hankinson
Journal:  Mol Pharmacol       Date:  2002-02       Impact factor: 4.436

2.  Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor.

Authors:  Y Shimizu; Y Nakatsuru; M Ichinose; Y Takahashi; H Kume; J Mimura; Y Fujii-Kuriyama; T Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Functional involvement of the Brahma/SWI2-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex.

Authors:  Song Wang; Oliver Hankinson
Journal:  J Biol Chem       Date:  2002-01-22       Impact factor: 5.157

4.  Methylation at arginine 17 of histone H3 is linked to gene activation.

Authors:  Uta-Maria Bauer; Sylvain Daujat; Søren J Nielsen; Karl Nightingale; Tony Kouzarides
Journal:  EMBO Rep       Date:  2001-12-19       Impact factor: 8.807

5.  The hsp90 Co-chaperone XAP2 alters importin beta recognition of the bipartite nuclear localization signal of the Ah receptor and represses transcriptional activity.

Authors:  John R Petrulis; Ann Kusnadi; Preeti Ramadoss; Brett Hollingshead; Gary H Perdew
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

6.  Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential.

Authors:  M B Kumar; G H Perdew
Journal:  Gene Expr       Date:  1999

7.  Recruitment of the NCoA/SRC-1/p160 family of transcriptional coactivators by the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator complex.

Authors:  Timothy V Beischlag; Song Wang; David W Rose; Joseph Torchia; Suzanne Reisz-Porszasz; Khurshid Muhammad; Walter E Nelson; Markus R Probst; Michael G Rosenfeld; Oliver Hankinson
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

8.  Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor.

Authors:  Eli V Hestermann; Myles Brown
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

9.  The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO-1 conjugation system.

Authors:  Masahide Tojo; Kazuhito Matsuzaki; Takeshi Minami; Yoshiomi Honda; Hideyo Yasuda; Tsutomu Chiba; Hideyuki Saya; Yoshiaki Fujii-Kuriyama; Mitsuyoshi Nakao
Journal:  J Biol Chem       Date:  2002-09-26       Impact factor: 5.157

10.  Critical enhancer region to which AhR/ARNT and Sp1 bind in the human CYP1B1 gene.

Authors:  Yuki Tsuchiya; Miki Nakajima; Tsuyoshi Yokoi
Journal:  J Biochem       Date:  2003-05       Impact factor: 3.387

View more
  23 in total

1.  Potential role of epigenetic mechanisms in the regulation of drug metabolism and transport.

Authors:  Magnus Ingelman-Sundberg; Xiao-Bo Zhong; Oliver Hankinson; Sudheer Beedanagari; Ai-Ming Yu; Lai Peng; Yoichi Osawa
Journal:  Drug Metab Dispos       Date:  2013-08-05       Impact factor: 3.922

2.  3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters.

Authors:  Andrea Pansoy; Shaimaa Ahmed; Eivind Valen; Albin Sandelin; Jason Matthews
Journal:  Toxicol Sci       Date:  2010-03-26       Impact factor: 4.849

3.  Perspectives on the potential involvement of the AH receptor-dioxin axis in cardiovascular disease.

Authors:  Alvaro Puga
Journal:  Toxicol Sci       Date:  2010-12-30       Impact factor: 4.849

4.  Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs.

Authors:  D P Jackson; A D Joshi; C J Elferink
Journal:  Toxicol Res (Camb)       Date:  2015-03-17       Impact factor: 3.524

5.  Homocitrullination Is a Novel Histone H1 Epigenetic Mark Dependent on Aryl Hydrocarbon Receptor Recruitment of Carbamoyl Phosphate Synthase 1.

Authors:  Aditya D Joshi; Mehnaz G Mustafa; Cheryl F Lichti; Cornelis J Elferink
Journal:  J Biol Chem       Date:  2015-09-30       Impact factor: 5.157

6.  Differential suppression of the aryl hydrocarbon receptor nuclear translocator-dependent function by an aryl hydrocarbon receptor PAS-A-derived inhibitory molecule.

Authors:  Jinghang Xie; Xin Huang; Miki S Park; Hang M Pham; William K Chan
Journal:  Biochem Pharmacol       Date:  2014-01-28       Impact factor: 5.858

7.  Inhibition of aryl hydrocarbon receptor-dependent transcription by resveratrol or kaempferol is independent of estrogen receptor α expression in human breast cancer cells.

Authors:  Laura Macpherson; Jason Matthews
Journal:  Cancer Lett       Date:  2010-09-16       Impact factor: 8.679

8.  Alterations of Histone Modifications Contribute to Pregnane X Receptor-Mediated Induction of CYP3A4 by Rifampicin.

Authors:  Liang Yan; Yiting Wang; Jingyang Liu; Yali Nie; Xiao-Bo Zhong; Quancheng Kan; Lirong Zhang
Journal:  Mol Pharmacol       Date:  2017-05-25       Impact factor: 4.436

9.  Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes.

Authors:  Sudheer R Beedanagari; Ilona Bebenek; Peter Bui; Oliver Hankinson
Journal:  Toxicol Sci       Date:  2009-04-17       Impact factor: 4.849

10.  Aryl hydrocarbon receptor (AHR) regulation of L-Type Amino Acid Transporter 1 (LAT-1) expression in MCF-7 and MDA-MB-231 breast cancer cells.

Authors:  Justin K Tomblin; Subha Arthur; Donald A Primerano; Ateeq R Chaudhry; Jun Fan; James Denvir; Travis B Salisbury
Journal:  Biochem Pharmacol       Date:  2016-03-02       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.